Last reviewed · How we verify
NCT04225104
Yogic Breathing and IBS
NA trial testing Yogic breathing intervention in IBS - Irritable Bowel Syndrome in 14 participants. Completed in 1 March 2020.
1 February 2020
Quick facts
| Lead sponsor | Texas State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 14 |
| Start date | 15 April 2019 |
| Primary completion | 1 February 2020 |
| Estimated completion | 1 March 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Yogic breathing intervention
Conditions studied
- IBS - Irritable Bowel Syndrome — all drugs for IBS - Irritable Bowel Syndrome →
Sponsor
Texas State University
Who can join
Adults 18 to 65, any sex, with IBS - Irritable Bowel Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Adults with irritable bowel syndrome (IBS) are being randomized to a yogic breathing or control condition. Participants randomized to the yogic breathing group will be asked to complete a 2-minute yogic breathing video 5 to 7 days per week at home for 4 weeks and control group participants will be asked to maintain their current activities. Participants in this group will be given access to the yogic breathing video at the end of the 4-week control period. IBS symptoms and autonomic and vascular function will be assessed at baseline and at the end of week 4 in both groups.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04225104
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for IBS - Irritable Bowel Syndrome
Currently open trials in the same condition.
- NCT06993272 — Relaxation Music for Chronic Pain · NA · active not recruiting
- NCT06684470 — Novel Pilot Study to Treat Symptoms of IBS With Diarrhea Using Combination Therapy of a Low-FODMAP Diet and a Neuromodul · EARLY_PHASE1 · recruiting
- NCT06117865 — Digital Treatment of Irritable Bowel Syndrome (IBS) · NA · active not recruiting
- NCT06215222 — Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease · recruiting
- NCT05815602 — Ebastine Versus Mebeverine in IBS Patients · Phase 3 · recruiting
Other Texas State University trials
Trials by the same sponsor.
- NCT06986135 — The Effect of Breathing on Cognitive Performance and Stress · NA · completed
- NCT06680908 — Impact of Combined Stress on Biomarkers of Stress · completed
- NCT05815043 — Effects of Sodium Intake on Arterial Stiffness in Black Men and Women · NA · completed
- NCT05158205 — Yoga in Altering Mechanistic Outcomes in Hypertension · NA · terminated
- NCT05592561 — Impact of Supplements on Stress Markers · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04225104 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Texas State University
- Last refreshed: 6 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04225104.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing